Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2018 2
2019 4
2020 1
2021 4
2022 9
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.
Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M. Taki M, et al. Clin Cancer Res. 2021 Sep 1;27(17):4669-4679. doi: 10.1158/1078-0432.CCR-20-4459. Epub 2021 Apr 7. Clin Cancer Res. 2021. PMID: 33827891 Review.
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer.
Ukita M, Hamanishi J, Yoshitomi H, Yamanoi K, Takamatsu S, Ueda A, Suzuki H, Hosoe Y, Furutake Y, Taki M, Abiko K, Yamaguchi K, Nakai H, Baba T, Matsumura N, Yoshizawa A, Ueno H, Mandai M. Ukita M, et al. Among authors: taki m. JCI Insight. 2022 Jun 22;7(12):e157215. doi: 10.1172/jci.insight.157215. JCI Insight. 2022. PMID: 35552285 Free PMC article.
B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M. Miyamoto T, et al. Among authors: taki m. Cancer Immunol Res. 2022 Jan;10(1):56-69. doi: 10.1158/2326-6066.CIR-21-0407. Epub 2021 Nov 19. Cancer Immunol Res. 2022. PMID: 34799346 Free PMC article.
Mini-review: Immunology in ovarian cancer.
Taki M. Taki M. J Obstet Gynaecol Res. 2023 Sep;49(9):2245-2251. doi: 10.1111/jog.15730. Epub 2023 Jul 6. J Obstet Gynaecol Res. 2023. PMID: 37415252 Review.
Aplastic Anemia Treated with Eltrombopag during Pregnancy.
Suminaga Y, Chigusa Y, Kondo T, Okamoto H, Kawamura Y, Taki M, Mandai M, Mogami H. Suminaga Y, et al. Among authors: taki m. Case Rep Obstet Gynecol. 2022 Feb 25;2022:5889427. doi: 10.1155/2022/5889427. eCollection 2022. Case Rep Obstet Gynecol. 2022. PMID: 35251724 Free PMC article.
Development of healthy lifestyle consciousness index for gynecological cancer patients.
Higashiyama N, Yamaguchi K, Yamamoto Y, Ueda A, Inayama Y, Egawa M, Yamanoi K, Taki M, Ukita M, Hosoe Y, Horie A, Hamanishi J, Mandai M. Higashiyama N, et al. Among authors: taki m. Support Care Cancer. 2022 Sep;30(9):7569-7574. doi: 10.1007/s00520-022-07179-z. Epub 2022 Jun 8. Support Care Cancer. 2022. PMID: 35674795 Free PMC article.
Nivolumab for malignant transformation of ovarian mature cystic teratoma.
Yoshimura K, Yamanoi K, Kanai M, Okunomiya A, Sagae Y, Sunada M, Taki M, Ukita M, Chigusa Y, Horie A, Yamaguchi K, Hamanishi J, Minamiguchi S, Yamamoto N, Muto M, Mandai M. Yoshimura K, et al. Among authors: taki m. Gynecol Oncol Rep. 2022 Dec 10;44:101115. doi: 10.1016/j.gore.2022.101115. eCollection 2022 Dec. Gynecol Oncol Rep. 2022. PMID: 36560959 Free PMC article.
Management of fetal death with placenta previa.
Taki M, Sato Y, Kakui K, Tatsumi K, Fujiwara H, Konishi I. Taki M, et al. J Matern Fetal Neonatal Med. 2012 Feb;25(2):196-9. doi: 10.3109/14767058.2011.560624. Epub 2011 Mar 10. J Matern Fetal Neonatal Med. 2012. PMID: 21391757 Free article. Review.
32 results